Last Updated: 19 Sep 2024
Executive Summary
Envista Holdings Corp. (NVST) is a leading dental equipment and supplies company with a market capitalization of $3.29 billion. Despite recent challenges, the company has a strong financial position with positive revenue growth and an improving profit margin. Analysts are generally optimistic about the stock, with a consensus rating of "Hold" and a target price of $17.56.
Company Overview
Envista Holdings Corporation develops, manufactures, and markets dental products worldwide. The company's products include dental implants, restorative materials, endodontic instruments, and orthodontic appliances. Envista has a global presence with operations in over 100 countries.
Fundamental Analysis
Revenue: Envista's revenue has grown steadily in recent years, reaching $2.53 billion in the trailing twelve months (TTM).
Earnings: The company has reported a net loss in the past four quarters, with a diluted EPS of -$7.74 in the TTM.
Profitability: Envista's profit margin has been negative in recent quarters, indicating that the company is not yet profitable. However, the operating margin has improved to 0.01% in the TTM.
Balance Sheet: Envista has a strong balance sheet with $1.73 billion in cash and equivalents and $1.24 billion in total debt.
Valuation: Based on the latest stock price of $19.18, Envista trades at a forward PE ratio of 15.38 and a price-to-sales ratio of 1.302.
Technical Analysis
Trend: NVST is currently in a downtrend, with the stock price below its 50-day and 200-day moving averages.
Support and Resistance: The stock has support at $17.56, the analyst target price, and resistance at $20.06, the 200-day moving average.
Momentum: The stock's momentum is negative, as indicated by the MACD and RSI indicators.
Short Term Outlook
In the short term, NVST is likely to continue to trade in a range between $17.56 and $20.06. The stock may face headwinds from continued economic uncertainty and supply chain disruptions.
Long Term Outlook
In the long term, Envista Holdings has the potential to be a successful company. The dental industry is expected to grow in the coming years, and Envista is well-positioned to capitalize on this growth. However, the company needs to improve its profitability and address the challenges facing the industry.
Analyst Recommendations
Analysts have a consensus rating of "Hold" on NVST, with a target price of $17.56. Two analysts have a "Strong Buy" rating, one has a "Buy" rating, eight have a "Hold" rating, one has a "Sell" rating, and none have a "Strong Sell" rating.
